ACTU

insider transactions

ACTUATE THERAPEUTICS, INC. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Grant·A
May 21, 26

Dan Zabrowski

Director

$0

15.0K sh

Own New
Grant·A
May 21, 26

Todd S Thomson

Director, 10% Owner

$0

15.0K sh

Own New
Grant·A
May 21, 26

Roger Sawhney

Director

$0

15.0K sh

Own New
Grant·A
May 21, 26

Amy L Ronneberg

Director

$0

15.0K sh

Own New
Grant·A
May 21, 26

Jason A Keyes

Director

$0

15.0K sh

Own New
Grant·A
May 21, 26

Martin H. Huber Jr.

Director

$0

15.0K sh

Own New
Grant·A
May 21, 26

Aaron G.L. Fletcher

Director, 10% Owner

$0

15.0K sh

Own New
Grant·A
Apr 1, 26

Daniel M Schmitt KEY

President, CEO and Director

$0

237.0K sh

Own New
Grant·A
Apr 1, 26

Andrew Paul Mazar

Chief Operating Officer

$0

105.0K sh

Own New
Grant·A
Apr 1, 26

Paul J Lytle KEY

Chief Financial Officer

$0

105.0K sh

Own New

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
May 21, 2026	Dan Zabrowski	Director	Grant A	15.0K	New	—	$0
May 21, 2026	Todd S Thomson	Director, 10% Owner	Grant A	15.0K	New	—	$0
May 21, 2026	Roger Sawhney	Director	Grant A	15.0K	New	—	$0
May 21, 2026	Amy L Ronneberg	Director	Grant A	15.0K	New	—	$0
May 21, 2026	Jason A Keyes	Director	Grant A	15.0K	New	—	$0
May 21, 2026	Martin H. Huber Jr.	Director	Grant A	15.0K	New	—	$0
May 21, 2026	Aaron G.L. Fletcher	Director, 10% Owner	Grant A	15.0K	New	—	$0
Apr 1, 2026	Daniel M Schmitt KEY	President, CEO and Director	Grant A	237.0K	New	—	$0
Apr 1, 2026	Andrew Paul Mazar	Chief Operating Officer	Grant A	105.0K	New	—	$0
Apr 1, 2026	Paul J Lytle KEY	Chief Financial Officer	Grant A	105.0K	New	—	$0

About ACTU insider trading

This page tracks insider transactions for ACTUATE THERAPEUTICS, INC. (ACTU) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.